Literature DB >> 219007

Circadian cortisol secretory rhythms in Cushing's disease.

R M Boyar, M Witkin, A Carruth, J Ramsey.   

Abstract

Plasma cortisol was measured at 20-min intervals for 24 h in eight patients with Cushing's disease and ACTH-secreting pituitary tumors. The 24-h mean (+/- SD) cortisol level was 25.6 +/- 11.3 microgram/dl (range, 15.5--40.6), which was significantly higher than the level of normal control subjects (P less than 0.01). The 24-h mean ACTH level varied between 22--107 pg/ml, with a mean +/- SD of 63.4 +/- 27.2. The mean ACTH level was higher than that of the control subjects but the difference was not statistically significant. The 24-h cortisol secretory pattern was characterized by an absence of the normal circadian variation and a failure of the plasma cortisol level to fall to less than 2 microgram/dl between 2300--0300 h. The coefficient of variation, an expression of the amplitude of cortisol secretory episodes, was significantly decreased in patients with Cushing's disease compared to normal control subjects; there was no significant difference in the number of cortisol secretory episodes in the patients vs. control subjects. Three of the patients were restudied after successful resection of their ACTH-secreting pituitary tumors. Two showed normalization of their 24-h circadian cortisol patterns and normal metyrapone responses. In the third, the 24-h mean cortisol level was normal, but the circadian cortisol rhythm remained abnormal. This patient had diminished ACTH reserve, demonstrated by a subnormal response to metyrapone. Additional studies will be required to determine if normalization of the circadian cortisol rhythm occurs in all patients with Cushing's disease who are cured after transsphenoidal microsurgery and who also show normal ACTH reserve.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219007     DOI: 10.1210/jcem-48-5-760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.

Authors:  J M Cunningham; O M Buxton; R E Weiss
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  Endogenous ACTH concentration-cortisol secretion dose analysis unmasks decreased ACTH potency in Cushing's disease with restoration after successful pituitary adenomectomy.

Authors:  Ferdinand Roelfsema; Daniel M Keenan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

3.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

4.  Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.

Authors:  R Görges; G Knappe; H Gerl; M Ventz; F Stahl
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

5.  Adrenal Vein Cortisol to Metanephrine Ratio for Localizing ACTH-Independent Cortisol-Producing Adenoma: A Case Report.

Authors:  Rishi Raj; Philip A Kern; Neelima Ghanta; Edilfavia M Uy; Kamyar Asadipooya
Journal:  J Endocr Soc       Date:  2021-01-25

Review 6.  Circadian Metabolomics in Time and Space.

Authors:  Kenneth A Dyar; Kristin L Eckel-Mahan
Journal:  Front Neurosci       Date:  2017-07-11       Impact factor: 4.677

7.  Sleep deprivation influences diurnal variation of human time perception with prefrontal activity change: a functional near-infrared spectroscopy study.

Authors:  Takahiro Soshi; Kenichi Kuriyama; Sayaka Aritake; Minori Enomoto; Akiko Hida; Miyuki Tamura; Yoshiharu Kim; Kazuo Mishima
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

Review 8.  New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.

Authors:  Maria Fleseriu; Stephan Petersenn
Journal:  J Neurooncol       Date:  2013-05-15       Impact factor: 4.130

Review 9.  Dynamics of ACTH and Cortisol Secretion and Implications for Disease.

Authors:  Stafford L Lightman; Matthew T Birnie; Becky L Conway-Campbell
Journal:  Endocr Rev       Date:  2020-06-01       Impact factor: 19.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.